Managing Director, Business Development, Pharmaceutical Diagnostics (PDx) jobs in United States
cer-icon
Apply on Employer Site
company-logo

GE HealthCare · 15 hours ago

Managing Director, Business Development, Pharmaceutical Diagnostics (PDx)

GE HealthCare is a leading company in the healthcare sector, and they are seeking a Managing Director for Business Development in Pharmaceutical Diagnostics. The role involves driving the PDx segment’s strategy for growth through managing a pipeline of inorganic growth initiatives, including partnerships and mergers.

AppsHealth CareHealth DiagnosticsHome ImprovementHome RenovationInternetMedical
check
Growth Opportunities

Responsibilities

Manage all aspects of inorganic strategy deployment for assigned business units, including market evaluation, target identification, screening, due diligence, structuring, negotiation and closing
Lead cross-functional teams, including marketing, engineering, finance, legal, supply chain, service, and HR in support of the evaluation and execution planning for M&A. Effectively manage communication and alignment with key internal stakeholders for assigned business units
Effectively lead team of direct reports in delivering on business development goals of assigned business units, providing coaching and development to build talent pipeline of function
Steward an effective decision making and approval process alongside GE’s corporate business development team in evaluation and execution of M&A transactions for assigned business units
Facilitate smooth transition of knowledge, integration responsibilities, and operating goals and objectives to business and functional leaders responsible for post-closing management
Communicate recommended inorganic strategies and business plans to executive leadership teams
Monitor integration status of transactions that have closed within the prior two years
Build and maintain effective network of stakeholders within markets of interest to assigned business units; utilize network to build strong understanding of market fundamentals, trends, and valuation
Promote utilization and continuous improvement of standardized business development practices, tools, and document retention policies

Qualification

Business DevelopmentM&A TransactionsHealthcare Industry ExperienceStrategic AlliancesTeam LeadershipProject ManagementMBA QualificationPartnership ProgramsCommunication SkillsInterpersonal SkillsProblem-Solving SkillsClear ThinkingNegotiation SkillsFacilitation Skills

Required

BA or BS degree
Minimum 10 years of experience and with a minimum of 5 years of relevant business development experience in a corporate, investment banking, or consulting environment
Healthcare/medical device/medtech industry experience
Strong communication and interpersonal skills
Demonstrated experience in sourcing, negotiating, and closing multiple, material M&A transactions
Demonstrated aptitude for both managing and prioritizing multiple projects and initiatives
Team leadership, project management and facilitation skills in a matrixed organization and interacting with senior executives, both internally and externally
Strong problem-solving skills
Clear thinking: Proven experience simplifying strategy into specific actions with clear accountability, making decisions with speed and accuracy despite ambiguity based on best available information, and communicating priorities clearly and concisely

Preferred

MBA qualification
Biopharmaceutical, specialty pharmaceutical, and/or imaging agents industry experience
Experience in the domain of establishing or managing partnership programs

Benefits

Medical
Dental
Vision
Paid time off
A 401(k) plan with employee and company contribution opportunities
Life
Disability
Accident insurance
Tuition reimbursement

Company

GE HealthCare

company-logo
GE Healthcare provides a wide range of medical technologies and services to healthcare providers and researchers. It is a sub-organization of General Electric.

Funding

Current Stage
Public Company
Total Funding
$5.52B
Key Investors
Bill & Melinda Gates Foundation
2024-11-07Post Ipo Secondary· $1.17B
2024-09-12Post Ipo Secondary· $1.29B
2024-02-16Post Ipo Secondary· $1.07B

Leadership Team

leader-logo
Catherine Estrampes
President and CEO, US & Canada
linkedin
leader-logo
Luiz Verzegnassi
President & CEO, Services
linkedin
Company data provided by crunchbase